12 major claims checked against the paper's own evidence: all adequately supported.
partialAbstract, sentence 6Reviewer 1
Our work demonstrates a general approach to fully inactivate the recipient cell genome.
The approach is shown with two crosslinkers (MMC and psoralen), but only one bacterial species is used as recipient. The generality across diverse bacteria is not directly demonstrated.
Evidence: Figure 4 shows results with psoralen, but only M. capricolum is tested.
“Our work demonstrates a general approach to fully inactivate the recipient cell genome, reports the first living synthetic bacterial cell constructed from non-living parts, and advances WGT for building engineered or synthetic cells for diverse applications.”
partialResults, Crosslinking DNA Generates Zombie CellsReviewer 1
The approach can be extended to other crosslinkers (psoralen).
The paper shows that psoralen treatment yields transplants, but only at very low efficiency (≈10% of MMC) and within a narrow concentration range. The generalization is limited.
Evidence: Figure 4a shows that psoralen at 0.04 μg/mL with 30 min UVA yields some transplants, but efficiency is much lower than MMC.
“In contrast to MMC, psoralen was significantly more cytotoxic and supported WGT only within a narrow range of concentration, yielding ≈ 10 % WGT efficiency.”
partialDiscussion, paragraph 2Reviewer 2
Our results overcome an outstanding technical challenge preventing WGT beyond Mycoides group.
The paper addresses the homologous recombination issue within the Mycoides group, but acknowledges that other barriers (e.g., endonucleases) remain, so the claim is partially supported.
Evidence: The paper discusses the remaining hurdles, such as calcium-activated endonucleases in other bacteria, indicating that the challenge is not fully overcome.
“Despite our progress here, the extension of WGT beyond the Mycoides taxon of mycoplasmas faces additional hurdles.”
partialConclusionReviewer 3
Selection-free WGT advances WGT for building engineered or synthetic cells for diverse applications.
The method is demonstrated only in one recipient-donor pair; remaining challenges (endonuclease, species barriers) are acknowledged.
Evidence: Discussion mentions need to overcome calcium-dependent endonucleases and other species-specific barriers.
“advances WGT for building engineered or synthetic cells for diverse applications”
supportedAbstract, sentence 1Reviewers 1, 2
We present a living, synthetic bacterial cell made by transplanting a complete genome into a dead cell.
The paper provides evidence that MMC-treated (dead) cells can be revived by transplanting a synthetic genome, as shown by colony growth, PCR confirmation, and growth in selective media.
Evidence: Figures 2 and 3 show transplant counts, growth on plates, and PCR confirmation of the JCVI-syn1.0 genome.
“We present a living, synthetic bacterial cell made by transplanting a complete genome into a dead cell.”
supportedAbstract, sentence 6 (same as above)Reviewer 1
Reports the first living synthetic bacterial cell constructed from non-living parts.
The paper shows that a dead cell (with chemically inactivated genome) can be revived by a synthetic genome, which is the first such demonstration.
Evidence: Results show that MMC-treated cells (no viable recipient genome) yield transplant colonies that express the donor genome.
“reports the first living synthetic bacterial cell constructed from non-living parts”
supportedDiscussion, paragraph 1Reviewer 1
Advances WGT for building engineered or synthetic cells for diverse applications.
The selection-free method eliminates the need for antibiotic markers, which is a key advance for applying WGT to other species. The paper discusses future applications.
Evidence: The Discussion states that the work overcomes the homologous recombination barrier and promises to pair synthetic DNA writing with transplantation.
“Here, selection-free WGT using dead recipient cells with a chemical crosslinked genome circumvented the challenge posed by homologous recombination that prevented intra-species WGT in non-Mycoides group Mollicutes bacteria.”
supportedResults, Selection-free WGTReviewer 1
MMC treatment of recipient cells eliminates need for antibiotic selection.
The paper directly shows that transplant colonies grow on plates without tetracycline, and recipient cells that survive MMC do not grow without selection, confirming that the donor genome is required for growth.
Evidence: Figure 3 shows plates with and without tetracycline; blue colonies (transplants) grow on both, while white colonies (recipients) only grow without tetracycline.
“This indicated that inactivation of the recipient genome by a DNA crosslinking agent eliminated the need for selection, as recipient cell genome was suppressed.”
supportedResults, Crosslinking DNA Generates Zombie CellsReviewer 1
Zombie cells are generated by DNA crosslinking.
The paper demonstrates that MMC and psoralen both crosslink DNA and kill cells, and that such cells can be revived by genome transplantation. This supports the concept of zombie cells.
Evidence: Figure 4 shows that psoralen treatment also yields transplants, albeit with lower efficiency.
“To test whether DNA crosslinking of recipient genomes provides a general strategy for generating zombie cells, we examined an alternate chemical to induce replication-blocking DNA lesions prior to WGT.”
supportedResults, Selection-free WGTReviewer 2
This overcomes a major limitation of WGT: reliance on antibiotic selection.
The paper demonstrates that MMC-treated recipient cells can be revived without antibiotic selection, as shown by growth on antibiotic-free plates, and the efficiency is comparable to standard WGT.
Evidence: Selection-free WGT yields blue colonies on plates without tetracycline (Figure 3a); white colonies (recipient cells) also grow but are distinguished by color.
“This indicated that inactivation of the recipient genome by a DNA crosslinking agent eliminated the need for selection, as recipient cell genome was suppressed.”
supportedAbstract, DiscussionReviewer 2
This is the first construction of a living synthetic bacterial cell from non-living parts.
The paper presents a novel method where a dead cell (with a chemically inactivated genome) is revived by a synthetic genome, which is a conceptual advance. The evidence supports the claim that they have constructed such a cell.
Evidence: The paper shows that transplantation into MMC-treated cells yields viable transplants, and the authors argue that the recipient cells are dead prior to genome installation.
“Our work demonstrates a general approach to fully inactivate the recipient cell genome, reports the first living synthetic bacterial cell constructed from non-living parts...”
supportedDiscussion, paragraph 3Reviewer 2
The use of zombie cells redefines dead versus living as a distinction between genome replication rather than cellular viability.
The paper provides a conceptual framework where 'dead' is defined by the inability to replicate due to genome inactivation, and demonstrates that such cells can be revived by installing a new genome, supporting the redefinition.
Evidence: The paper shows that MMC-treated cells (which cannot replicate their own genome) can still support transcription and translation and be revived by transplantation.
“Our findings suggest that naturally-evolved biology routinely may operate across a porous boundary between life and death, and this boundary can now be intentional and engineerable.”